CeriBell, Inc. (CBLL)
| Market Cap | 868.50M |
| Revenue (ttm) | 54.46M |
| Net Income (ttm) | -32.79M |
| Shares Out | 34.02M |
| EPS (ttm) | -6.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 335,741 |
| Open | 25.50 |
| Previous Close | 25.50 |
| Day's Range | 25.01 - 26.20 |
| 52-Week Range | 24.10 - 26.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CBLL
CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring... [Read more]
News
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
SUNNYVALE, Calif. , Oct. 15, 2024 /PRNewswire/ -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of pati...
CeriBell IPO: Stock price will be closely watched today as the AI brain-monitoring headband maker debuts on the Nasdaq
CeriBell, a neurodiagnostic startup known for its brain-monitoring headband that can detect seizure activity, is making its market debut on Friday in an IPO that is expected to generate $180.3 million...
Ceribell's stock indicates up 35% in trading debut after pricing IPO at top of range
Ceribell Inc., a medical-device maker that uses artificial intelligence to monitor patient seizures, was on track for a strong trading debut Friday, after its initial public offering priced at the top...
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering
SUNNYVALE, Calif. , Oct. 10, 2024 /PRNewswire/ -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of pati...
Seizure diagnostic company Ceribell files for a $100 million IPO
Ceribell, which has developed an electroencephalography platform to diagnose and monitor patients at risk of seizures, filed on Monday with the SEC to raise up to $100 million in an initial public off...
CeriBell IPO Registration Document (S-1)
CeriBell has filed to go public with an IPO on the NASDAQ.